These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17587676)

  • 1. High-level expression of fusion protein containing 10 tandem repeated GLP-1 analogs in yeast Pichia pastoris and its biological activity in a diabetic rat model.
    Hou J; Yan R; Yang L; Wu Z; Wang C; Ding D; Li N; Ma C; Li M
    Biosci Biotechnol Biochem; 2007 Jun; 71(6):1462-9. PubMed ID: 17587676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification, and characterization of recombinant human serum albumin fusion protein with two human glucagon-like peptide-1 mutants in Pichia pastoris.
    Dou WF; Lei JY; Zhang LF; Xu ZH; Chen Y; Jin J
    Protein Expr Purif; 2008 Sep; 61(1):45-9. PubMed ID: 18556214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step purification of a fusion protein of glucagon-like peptide-1 and human serum albumin expressed in pichia pastoris by an immunomagnetic separation technique.
    Chen J; Bai G; Cao Y; Gao Z; Zhang Q; Zhu Y; Yang W
    Biosci Biotechnol Biochem; 2007 Nov; 71(11):2655-62. PubMed ID: 17986790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats.
    Hou J; Yan R; Ding D; Yang L; Wang C; Wu Z; Yu X; Li W; Li M
    Biotechnol Lett; 2007 Oct; 29(10):1439-46. PubMed ID: 17581704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of optimized rolGLP-1, a novel GLP-1 analog, in Escherichia coli BL21(DE3) and its good glucoregulatory effect on type 2 diabetic mice.
    Ma B; Tu P; Zhao X; Zhang Y; Wang Y; Ma C; Ji Y; Li X; Abbas SA; Li M
    Curr Pharm Biotechnol; 2013; 14(11):985-94. PubMed ID: 24372241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
    Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-level expression of fusion protein GGH in Pichia pastoris GS115 by constructing a double plasmid co-expression system].
    Wang H; Dou W; Zhang X; Xu H; Xu Z
    Sheng Wu Gong Cheng Xue Bao; 2011 Jul; 27(7):983-9. PubMed ID: 22016981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a glucagon-like peptide-1 analogue, as a therapeutic agent for type II diabetes, with enhanced bioactivity and increased N-terminal homogeneity in Pichia pastoris.
    Qian K; Li C; Gong X; Ndawula C; Qian J; Chen Y; Li H; Jin J
    Biotechnol Lett; 2015 Nov; 37(11):2229-35. PubMed ID: 26160109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
    Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
    J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cloning of PTD-NPY fusion gene and its secretory expression in Pichia pastoris].
    Sun Y; Zhou F; Wan J; Gao H
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1620-4. PubMed ID: 19160846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus.
    De León DD; Crutchlow MF; Ham JY; Stoffers DA
    Int J Biochem Cell Biol; 2006; 38(5-6):845-59. PubMed ID: 16202636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris.
    Zhou J; Chu J; Wang YH; Wang H; Zhuang YP; Zhang SL
    Biotechnol Lett; 2008 Apr; 30(4):651-6. PubMed ID: 18060365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, characterization, and evaluation of a fusion protein of a novel glucagon-like peptide-1 (GLP-1) analog and human serum albumin in Pichia pastoris.
    Gao Z; Bai G; Chen J; Zhang Q; Pan P; Bai F; Geng P
    Biosci Biotechnol Biochem; 2009 Mar; 73(3):688-94. PubMed ID: 19270384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
    Huang YS; Chen Z; Chen YQ; Ma GC; Shan JF; Liu W; Zhou LF
    J Pept Sci; 2008 May; 14(5):588-95. PubMed ID: 17994612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability.
    Youn YS; Chae SY; Lee S; Jeon JE; Shin HG; Lee KC
    Biochem Pharmacol; 2007 Jan; 73(1):84-93. PubMed ID: 17054919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human globular adiponectin-glucagon-like peptide-1 analog fusion protein and its assay of glucose-lowering effect in vivo.
    Zhao T; Lv J; Zhao J; Huang X; Xiao H
    Int J Med Sci; 2011 Mar; 8(3):203-9. PubMed ID: 21448306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice.
    Chung HS; Oh JY; Yoo SB; Lee SM; Cho HS
    Regul Pept; 2011 Oct; 170(1-3):1-3. PubMed ID: 21621561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.
    Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glucagon-like peptide-1 and its agonists on early prevention of cardiac remodeling in type 1 diabetic rat hearts.
    Barakat GM; Nuwayri-Salti N; Kadi LN; Bitar KM; Al-Jaroudi WA; Bikhazi AB
    Gen Physiol Biophys; 2011 Mar; 30(1):34-44. PubMed ID: 21460410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction expression and biologic activity of recombinant human sCR1 eucaryotic cell].
    Wang GL; Gong CC; Wang WL; Zhang CY; Liu YL; He PX; Zheng SN; Chen XL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):453-6. PubMed ID: 18466700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.